Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Dan‐yun Lai"'
Autor:
Qing Lei, Cai-zheng Yu, Yang Li, Hong-yan Hou, Zhao-wei Xu, Zong-jie Yao, Yan-di Zhang, Dan-yun Lai, Jo-Lewis Banga Ndzouboukou, Bo Zhang, Hong Chen, Zhu-qing Ouyang, Jun-biao Xue, Xiao-song Lin, Yun-xiao Zheng, Xue-ning Wang, He-wei Jiang, Hai-nan Zhang, Huan Qi, Shu-juan Guo, Mei-an He, Zi-yong Sun, Feng Wang, Sheng-ce Tao, Xiong-lin Fan
Publikováno v:
Journal of Advanced Research, Vol 36, Iss , Pp 133-145 (2022)
Introduction: The COVID-19 global pandemic is far from ending. There is an urgent need to identify applicable biomarkers for early predicting the outcome of COVID-19. Growing evidences have revealed that SARS-CoV-2 specific antibodies evolved with di
Externí odkaz:
https://doaj.org/article/0e91b364bd0f4852a99af707db6ab6c5
Autor:
Jun-biao Xue, Dan-yun Lai, He-wei Jiang, Huan Qi, Shu-juan Guo, Yuan-shou Zhu, Hong Xu, Jie Zhou, Sheng-ce Tao
Publikováno v:
Cell Discovery, Vol 8, Iss 1, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/a712c45e257f4e3da12b1f34222db514
Autor:
Ming-Liang Ma, Da-Wei Shi, Yang Li, Wei Hong, Dan-Yun Lai, Jun-Biao Xue, He-Wei Jiang, Hai-Nan Zhang, Huan Qi, Qing-Feng Meng, Shu-Juan Guo, De-Ju Xia, Jin-Jun Hu, Shuo Liu, He-Yang Li, Jie Zhou, Wei Wang, Xiao Yang, Xiong-Lin Fan, Qing Lei, Wei-Jun Chen, Ce-Sheng Li, Xiao-Ming Yang, Si-Hong Xu, Hong-Ping Wei, Sheng-Ce Tao
Publikováno v:
Cell Discovery, Vol 7, Iss 1, Pp 1-14 (2021)
Abstract One of the best ways to control COVID-19 is vaccination. Among the various SARS-CoV-2 vaccines, inactivated virus vaccines have been widely applied in China and many other countries. To understand the underlying protective mechanism of these
Externí odkaz:
https://doaj.org/article/fd0f1fa908204d01ac3048e77f128ef0
Publikováno v:
STAR Protocols, Vol 3, Iss 2, Pp 101238- (2022)
Summary: The immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteome is largely unknown. Here we describe a protocol for analyzing sera samples with SARS-CoV-2 proteome microarray. The proteins were expressed by either
Externí odkaz:
https://doaj.org/article/f68d7d7666424f4d9fdcdd6e103c58a8
Publikováno v:
STAR Protocols, Vol 2, Iss 3, Pp 100707- (2021)
Summary: Host humoral immunological response plays an essential role in protection against pathogens. Identification of B-cell epitopes on antigens is required for accurate diagnosis and vaccine development. To map SARS-CoV-2 (severe acute respirator
Externí odkaz:
https://doaj.org/article/29562ec173ef42afa04582817f5dee0a
Autor:
Yang Li, Zhaowei Xu, Qing Lei, Dan-yun Lai, Hongyan Hou, He-wei Jiang, Yun-xiao Zheng, Xue-ning Wang, Jiaoxiang Wu, Ming-liang Ma, Bo Zhang, Hong Chen, Caizheng Yu, Jun-biao Xue, Hai-nan Zhang, Huan Qi, Shu-juan Guo, Yandi Zhang, Xiaosong Lin, Zongjie Yao, Huiming Sheng, Ziyong Sun, Feng Wang, Xionglin Fan, Sheng-ce Tao
Publikováno v:
Cell Reports, Vol 36, Iss 2, Pp 109391- (2021)
Summary: The immunogenicity of the SARS-CoV-2 proteome is largely unknown, especially for non-structural proteins and accessory proteins. In this study, we collect 2,360 COVID-19 sera and 601 control sera. We analyze these sera on a protein microarra
Externí odkaz:
https://doaj.org/article/cdba430fbaa340038ec8e9d543016c7d
Autor:
Yang Li, Ming-liang Ma, Qing Lei, Feng Wang, Wei Hong, Dan-yun Lai, Hongyan Hou, Zhao-wei Xu, Bo Zhang, Hong Chen, Caizheng Yu, Jun-biao Xue, Yun-xiao Zheng, Xue-ning Wang, He-wei Jiang, Hai-nan Zhang, Huan Qi, Shu-juan Guo, Yandi Zhang, Xiaosong Lin, Zongjie Yao, Jiaoxiang Wu, Huiming Sheng, Yanan Zhang, Hongping Wei, Ziyong Sun, Xionglin Fan, Sheng-ce Tao
Publikováno v:
Cell Reports, Vol 34, Iss 13, Pp 108915- (2021)
Summary: To fully decipher the immunogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike protein, it is essential to assess which part is highly immunogenic in a systematic way. We generate a linear epitope landscape of
Externí odkaz:
https://doaj.org/article/47c8b794ca2844f29aa78af66e730aea
Autor:
Meian He, Bo Zhang, Ziyong Sun, Zhaowei Xu, Jun-biao Xue, Huan Qi, Caizheng Yu, Shu-Juan Guo, Yandi Zhang, He-wei Jiang, Hongyan Hou, Hong Chen, Hai-nan Zhang, Xue-ning Wang, Sheng-Ce Tao, Qing Lei, Yang Li, Dan-yun Lai, Jo-Lewis Banga Ndzouboukou, Zhuqing Ouyang, Xiaosong Lin, Zongjie Yao, Yun-xiao Zheng, Feng Wang, Xionglin Fan
Publikováno v:
Journal of Advanced Research, Vol 36, Iss, Pp 133-145 (2022)
Journal of Advanced Research
Journal of Advanced Research
Graphical abstract
Introduction The COVID-19 global pandemic is far from ending. There is an urgent need to identify applicable biomarkers for early predicting the outcome of COVID-19. Growing evidences have revealed that SARS-CoV-2 specific ant
Introduction The COVID-19 global pandemic is far from ending. There is an urgent need to identify applicable biomarkers for early predicting the outcome of COVID-19. Growing evidences have revealed that SARS-CoV-2 specific ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7713540e85c82abc11c1b9fe00e24dd9
https://doi.org/10.1016/j.jare.2021.11.014
https://doi.org/10.1016/j.jare.2021.11.014
Current advances in antibody-based serum biomarker studies: From protein microarray to phage display
Publikováno v:
Proteomics. Clinical applicationsREFERENCES. 16(6)
This review aims to summarize the technological advances in the field of antibody-based biomarker studies by proteome microarray and phage display. In addition, the possible development directions of this field are also discussed.We have focused on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6e5ae76872f937b9ad95287d61b3b7
https://pubmed.ncbi.nlm.nih.gov/36071670
https://pubmed.ncbi.nlm.nih.gov/36071670
Autor:
Shu-Juan Guo, He-wei Jiang, Chuansheng Hu, Nan Wang, Yani Kang, Yang Li, Zhaowei Xu, Hai-nan Zhang, Dan-yun Lai, Huan Qi, Hua Li, Fan-Lin Wu, Xiaodong Zhao, Qing-Feng Meng, Ming-liang Ma, Sheng-Ce Tao
Publikováno v:
Acta Biochimica et Biophysica Sinica. 53:628-635
PD-1 plays an important role as an immune checkpoint. Sintilimab is a newly approved PD-1 antibody for cancer immunotherapy with an unknown binding epitope on PD-1. In this study, to elucidate the molecular mechanism by which sintilimab blocks PD-1 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c1c7b63afde48e41675318506872f9
https://doi.org/10.1093/abbs/gmab020
https://doi.org/10.1093/abbs/gmab020